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Abstract 
Background: Acid–base imbalance has been reported to increase incidence of hypertension and diabetes. However, 
the association between diet‑induced acid load and cardiovascular disease (CVD) risk in the general population has 
not been fully investigated.
Methods: This was a population‑based, retrospectively registered cross‑sectional study using nationally representa‑
tive samples of 11,601 subjects from the Korea National Health and Nutrition Examination Survey 2008–2011. Indi‑
vidual CVD risk was evaluated using atherosclerotic cardiovascular disease (ASCVD) risk equations according to 2013 
ACC/AHA guideline assessment in subjects aged 40–79 without prior CVD. Acid–base status was assessed with both 
the potential renal acid load (PRAL) and the dietary acid load (DAL) scores derived from nutrient intake.
Results: Individuals in the highest PRAL tertile had a significant increase in 10 year ASCVD risks (9.6 vs. 8.5 %, P < 0.01) 
and tended to belong to the high‑risk (10 year risk >10 %) group compared to those in the lowest PRAL tertile (odds 
ratio [OR] 1.23, 95 % confidence interval [CI] 1.22–1.35). The association between higher PRAL score and high CVD risk 
was stronger in the middle‑aged group. Furthermore, a multiple logistic regression analysis also demonstrated this 
association (OR 1.20 95 % CI 1.01–1.43). Subgroup analysis stratified obesity or exercise status; individuals in unhealthy 
condition with lower PRAL scores had comparable ASCVD risk to people in the higher PRAL group that were in 
favorable physical condition. In addition, elevated PRAL scores were associated with high ASCVD risk independent of 
obesity, exercise, and insulin resistance, but not sarcopenia. Similar trends were observed with DAL scores.
Conclusion: Diet‑induced acid load was associated with increased risk of CVD, independent of obesity and insulin 
resistance.
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Background
Cardiovascular disease (CVD) has been a major cause of 
death around the world [1]. Although CVD mortality has 
decreased in developed countries in recent decades [1], 
CVD accounts for 46 % of total deaths in Europe [2] and 
creates high socioeconomic burdens, costing up to $320.1 
billion annually in the US [3]. There is no exception for 
Asian countries: CVD ranks the second for mortality 
cause in South Korea [4], and explains 25 % for all-cause 
death in Japan [5]. As nutritional imbalance is a risk factor 
for CVD, the American Heart Association (AHA) encour-
ages adequate intake of fruits and vegetables [3]. How-
ever, a Western diet induces an acid load that overwhelms 
the base production from vegetables, leading to chronic 
metabolic acidosis [6]. Recently, acid–base imbalance was 
suggested to be a risk factor for metabolic disorders [7–9]; 
higher dietary acid load increased the incidence of type 
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2 diabetes and hypertension in prospective studies [7, 8] 
and was associated with insulin resistance [9].
The diet-induced acid load is estimated using a for-
mula that accounts for organic compounds, including 
the potential renal acid load (PRAL), dietary acid load 
(DAL), and net endogenous acid production (NEAP). 
In comparison with NEAP, which is calculated from the 
ratio of ingested protein and potassium, PRAL and DAL 
calculations include other materials (calcium, phospho-
rus, and magnesium) along with protein and potassium. 
This discrepancy accounts for the bioavailability of nutri-
ents, enabling PRAL and DAL scores to give more accu-
rate predictions of dietary effects on body acidity [10, 11]. 
Negative values of PRAL and lower DAL values indicate 
base-forming potential, while positive PRAL scores and 
higher DAL scores reflect acid-forming potential [12].
To date, studies on acid–base homeostasis have focused 
on the relationship between dietary patterns and the risk 
of hypertension or metabolic diseases, but not CVDs. 
We hypothesized that diet-induced acid load increases 
the CVD risks regardless of other metabolic conditions. 
The aim of this study was to investigate the association 
between diet-induced acid load, using both PRAL and 
DAL scores, with CVD risk in the general population.
Methods
Study population
This cross-sectional study extracted participant results 
from the Korea National Health and Nutrition Exami-
nation Surveys (KNHANES) 2008–2011. As previously 
described in detail, the KNHANES is a nationwide, pop-
ulation-based, cross-sectional health examination and 
annual survey. The survey is conducted by the Division 
of Chronic Disease Surveillance of the Korea Centers for 
Disease Control and Prevention in the Ministry of Health 
and Welfare to monitor the public health and nutrition 
in South Korea [13]. Each KNHANES is composed of 
independent data sets from the general population of 
Korea. As described in Fig. 1, of 37,753 participants from 
KNHANES 2008–2011, we initially selected those aged 
40–79 without prior history of CVD. Subjects excluded 
were those with missing data for dietary intake and CVD 
risk assessment components. Ultimately, 11,601 subjects 
(4813 men and 6788 women) were included in the analy-
sis. All participants provided written informed consent. 
The survey protocol was approved by the institutional 
review board of the Korean Centers for Disease Control 
and Prevention (2008-04EXP-01-C, 2009-07CON-03-2C, 
2010-02CON-21-C, and 2011-02CON-06C).
Measurement of clinical and laboratory parameters
KNHANES data includes a 3-part medical history, nutri-
tional status, and laboratory tests. Subjects’ medical 
history was evaluated, including smoking, alcohol con-
sumption, exercise, and disease diagnosis or treatment, 
based on direct interviews and self-reporting. Regular 
exercise was defined as more than 20  min per session 
and at least 3 times per week, and heavy drinkers were 
defined as those whose alcohol consumption was >140 g/
week for men and >70 g/week for women. Blood pressure 
was manually measured using mercury sphygmomanom-
eters (Baumanometer; W.A. Baum, Copiague, NY) three 
times on the right arms of people in resting, seated posi-
tions, and final blood pressure values were assessed by 
averaging the second and third blood pressure readings. 
Appendicular skeletal muscle (ASM) was measured using 
dual-energy X-ray absorptiometry (DXA, QDR 4800A; 
Hologic Inc., Bedford, MA, USA) and was limited in 8690 
subjects. Overnight (8  h) fasting blood and spot urine 
samples were collected, refrigerated, and transported to 
the central laboratory institute (NeoDin Medical Insti-
tute, Seoul, South Korea) within 24  h. All biochemical 
samples were measured as previously described [14]. 
Estimated glomerular filtration rate (eGFR) was calcu-
lated using the Chronic Kidney Disease Epidemiology 
collaboration (CKD-EPI) equation [15]. The homeostasis 
model assessment of insulin resistance (HOMA-IR) was 
subtracted from the formula as previously described [16].
Cardiovascular disease definition and assessment
CVD risk was evaluated using various approaches, 
including the 10  year atherosclerotic vascular disease 
(ASCVD) risk score from the 2013 American College 
of Cardiology (ACC)/AHA guidelines, as well as the 
Framingham 10  year CVD risk score [17, 18]. In addi-
tion, individuals exhibiting >10 % of ACC/AHA ASCVD 
10  year risk and >20  % of Framingham CVD risk were 
classified into the high-risk group [17, 18]. Impaired fast-
ing glucose was defined as fasting plasma glucose ranging 
from 100 to 125 mg/dL without prior diabetes diagnosis. 
Diabetes was defined in subjects who were using oral 
anti-diabetic agents, or exhibited fasting plasma glucose 
≥126  mg/dL or glycated hemoglobin (HbA1c) ≥6.5  %. 
Subjects were considered to have hypertension if their 
systolic blood pressure was ≥140  mmHg, or their dias-
tolic blood pressure was ≥90  mmHg, or if they were 
taking anti-hypertensive medications. Body mass index 
(BMI) was evaluated using the ratio of weight to height 
(kg/m2), and overweight was defined based on the cri-
teria in the Asians (BMI ≥23  kg/m2) [19]. Chronic kid-
ney disease (CKD) was characterized in subject with less 
than 60  mL/min/1.73  m2, accordance with CKD guide-
line [20]. Sarcopenia was defined as an ASM divided by 
BMI (ASM/BMI) <0.789 for men and <0.512 for women, 
as recommended by the international consensus meeting 
from the Foundation for the National Institutes of Health 
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(FNIH) [21]. Because a standard definition of sarcopenia 
has not yet been established, ASM/height2 and ASM/
weight estimations were applied [22, 23]. Sarcopenia was 
defined as <2 standard deviations (SD) below the sex-
specific average for a young (age 18–39), healthy refer-
ence population from the datasets (2364 men and 3093 
women) [22–24]. The ASM/height2 cutoff was 6.44 kg/m2 
for men and 4.48  kg/m2 for women, whereas the ASM/
weight cutoff was 28.80 and 22.72 % for men and women, 
respectively [25]. An age cutoff point to define younger or 
older adults was 55, the median value.
Dietary acid load score assessment
Dietary intake information was collected by 1  day face-
to-face 24  h recall method by well-trained dietary inter-
viewers aided by various measuring devices (a common 
size container, standard measuring cups and spoons, a 
three-dimensional food model, or two-dimensional aids). 
Moreover, the quality control on interview at filed was 
conducted throughout the survey by the Center for Nutri-
tion Policy and Promotion at the Korea Health Industry 
Development Institute with the checklist of the control 
manual. The 24  h recall method provides high-quality 
nutrient data and has demonstrated its accuracy in other 
studies [26, 27]. Detailed information and data resource 
profile of the survey has been provided elsewhere [28]. 
To calculate PRAL, intake data were needed for pro-
tein, phosphorus, potassium, calcium, and magnesium. 
Because magnesium intake data were not available in 
KNHANES, daily magnesium intake values were esti-
mated using an external magnesium content database 
developed by another research group [29]. We matched 
the 5105 food items contained in the KNHANES 2008–
2011 to the magnesium content database of 366 foods 
commonly consumed by Koreans. Foods not included 
in the database were indirectly matched with simi-
lar foods in the database. Consumption frequencies of 
foods by this matching process contributed 65.4 % of the 
total consumption frequency in KNHANES. PRAL and 
DAL scores were derived from the equations of nutri-
ent intakes and tertiles of the scores were used for sta-
tistical analysis: PRAL (mEq/day)  =  (0.49  ×  protein [g/
day]) + (0.037 × phosphorus [mg/day]) − (0.021 × potas-
sium [mg/day])  −  (0.026  ×  magnesium [mg/
day]) − (0.013 × calcium [mg/day]) [30], and DAL (mEq/
day)  =  PRAL  +  (body surface area [m2]  ×  41 [mEq/
Total n=37,753 assessed for eligibility 
KNHANES IV-2 (2008, n=9,744) 
KNHANES IV-3 (2009, n=10,533) 
KNHANES V-1 (2010, n=8,958) 
KNHANES V-2 (2011, n=8,518) 
n=18,257, age 40-79 years  
Men (n=8,027) 
Women (n=10,230) 
Exclude those with age <40 years (n=18,623),  ≥80 
years (n=396) 
Final analysis set (n=11,601) 
Men (n=4,813) 
Women (n=6,788) 
Exclude those with prior cardiovascular disease 
(n=1,090)  
Exclude those with insufficient information to 
calculate ASCVD risk score (n=4,156), 
no data of dietary information (n=1,410)  
Fig. 1 The flow diagram of subject inclusion and exclusion in the Korean National Health and Nutrition Examination Surveys (KNHANES IV and V)
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day]/1.73  m2) [10]. Both PRAL and DAL score was cat-
egorized into sex-specific tertiles. Body surface area was 
calculated by the Du Bois formula: 0.007184 × height0.725 
× weight0.425 [31, 32]. Because data on body surface area 
were missing for 36 subjects, 11,565 subjects with DAL 
scores were newly categorized according to DAL tertiles.
Statistical analysis
Data are presented as the mean ± SD for continuous vari-
ables, and presented as number (N), or percent (%) for 
categorical variables. We analyzed the study participants’ 
characteristics according to PRAL tertiles, using one-way 
analysis of variance (ANOVA) to compare continuous 
variables, χ2 tests for categorical variables followed by post 
hoc analyses with the Bonferroni method. To evaluate the 
association between acid load and CVD risk, the effects 
of comorbidities should be minimized. Subjects were 
divided according to the presence of obesity, sarcopenia, 
and regular exercise, and then χ2 tests were applied for each 
group. The higher PRAL group included both the second 
and highest PRAL tertiles, and this group was compared 
against the lowest PRAL tertile. Multiple logistic regression 
analysis was used to assess the independent association 
between acid load and high CVD risk (>10 % of ACC/AHA 
ASCVD 10 year risk score or >20 % of Framingham 10 year 
risk score) including other covariates. Fasting insulin, 
HOMA-IR, total cholesterol, triglyceride, HDL cholesterol, 
and LDL cholesterol values were not normally distributed; 
analyses were performed using log- and back-transformed 
data. Statistical analyses were performed using IBM SPSS 
version 20.0 for Windows (IBM Corp., Armonk, NY, USA); 
P < 0.05 was considered statistically significant.
Results
Diet‑induced acid load and baseline characteristics
In total, 11,601 individuals free from CVD were analyzed 
in the present study (Fig.  1). Individuals with a higher 
diet-induced acid load (higher PRAL and DAL scores) 
tended to have increased blood pressure, triglyceride 
levels, and metabolic syndrome (Tables  1, 2). They also 
reported higher incidences of smoking cigarettes, drink-
ing alcohol, and exercising less. Estimated dietary acid–
base load also corresponded with urine acidity, reflecting 
the body’s acid–base homeostasis. In contrast, mean 
BMI, LDL, and HDL cholesterol and the proportions of 
CKD were similar across the PRAL tertiles. Regarding 
DAL scores, more discrepancies among the tertiles were 
observed; higher BMI, lower HDL and increased insulin 
resistance were found in the highest DAL tertile.
Diet‑induced acid load and cardiovascular disease risks
The average 10  year ACC/AHA ASCVD risk score 
increased as PRAL increased (from 8.5 to 9.6  %, 
P < 0.001, Fig. 2a), and the discrepancy among the tertiles 
was greater in the older age group (≥55 years) (Fig. 2b). 
Overall, the proportion of patients in the high-risk group 
(predicted 10 year risk of hard ACC/AHA ASCVD event 
>10 %) in our population was 32.6 %, and the distribution 
of high-risk group members and PRAL tertiles showed 
the same trend as ACC/AHA ASCVD scores (29.5 
and 34.0  % for lowest and highest tertiles, respectively, 
P < 0.001, Fig. 2c). The link between higher PRAL score 
and high-risk group classification was observed in older 
age group (Fig.  2d). Similarly, higher PRAL scores were 
associated with CVD risk that was estimated by a differ-
ent method, the Framingham 10 year risk score (Fig. 3). 
Regarding DAL score, the correlation between higher 
DAL score and increased ACC/AHA ASCVD score was 
only observed in young age group (Fig. 4). As CVD risk 
gradually increases according to age, we stratified sub-
jects using 10 year units, and evaluated PRAL scores and 
ASCVD risk scores (Fig. 5). The proportion of individu-
als with higher ASCVD risk was increased in the higher 
PRAL population, especially among middle-aged individ-
uals (50–59 years old). A similar trend was also observed 
using DAL scores.
Diet‑induced acid load is linked with CVD risk independent 
of obesity, exercise, and insulin resistance, but not 
sarcopenia
As overweight and low exercise are considered impor-
tant CVD risk factors, we stratified the study population 
according to these variables. Higher PRAL scores raised 
the proportion of high ACC/AHA ASCVD risk regard-
less of BMI (Odds Ratio [OR] ranged from 1.19 to 1.37, 
P < 0.05 for all groups), and this association was stronger 
in the lean group (Fig.  6a). Interestingly, lean subjects 
with higher PRAL scores exhibited a similar propor-
tion of higher CVD risk compared to those in the obese 
group. Although it was not statistically significant, more 
lean subjects with higher PRAL scores were in the ACC/
AHA ASCVD high-risk group than obese subjects with 
lower PRAL scores. A high-PRAL diet increased ACC/
AHA ASCVD risk group distribution independent of 
exercise status (OR ranged from 1.23 to 1.27, P < 0.05 for 
all groups, Fig. 6b). Moreover, the lowest PRAL individu-
als who did not exercise showed comparable ACC/AHA 
ASCVD risk with those in the higher PRAL group who 
regularly exercised. Increased ACC/AHA ASCVD risks 
in the higher PRAL group were also observed regard-
less of insulin resistance status assessed by HOMA-IR 
(Fig. 6c). Regarding skeletal muscle mass, the association 
between PRAL and high-risk ACC/AHA ASCVD was 
stronger among subjects with preserved skeletal muscle 
mass (OR 1.17, 95  % CI 1.06–1.30, Fig.  6d); this asso-
ciation was not observed among sarcopenic subjects 
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(OR 1.17, 95 % CI 0.81–1.69). This trend was consistently 
observed when other sarcopenia definitions were applied 
(Fig. 7).
Higher PRAL and DAL scores are associated with elevated 
predicted risk of CVD regardless of hypertension or 
diabetes
We assessed high predicted ASCVD risk and diet-
induced acid load after adjusting for confounding fac-
tors, including age, sex, and other clinic-laboratory 
parameters. Multiple logistic regression analysis showed 
that higher PRAL scores was independently associated 
with high risk of CVD evaluated from both ACC/AHA 
assessment and Framingham risk score (Tables 3, 4). The 
effects of PRAL on ACC/AHA ASCVD risk showed no 
significant difference in patients categorized by hyperten-
sion, by age or by overweight (hypertension; P =  0.345, 
age; P =  0.112, overweight; P =  0.150, respectively, for 
interaction). Although this statistical significance was 
weakened in DAL score, the similar trend was observed 
in DAL tertiles (Table 5).
Discussion
In this current large, nationally representative, popu-
lation-based study, we demonstrated that people with 
higher diet-induced acid load had higher CVD risks 
Table 1 Baseline characteristics of study population by categories of PRAL
PRAL potential renal acid load; DAL dietary acid load; BMI body mass index; HDL cholesterol, high density lipoprotein cholesterol; LDL cholesterol, low density 
lipoprotein cholesterol; eGFR estimated glomerular filtration rate; HOMA-IR homeostasis model assessment of insulin resistance; IFG impaired fasting glucose
‡ P < 0.05 by post hoc analyses when compared with lowest tertiles
* Chi square tests for qualitative variables and ANOVA tests for quantitative variables
a Values are medians per tertile
b Log-transformed
Tertiles of dietary PRAL (mEq/day) P value*
T1 (n = 3859) T2 (n = 3540) T3 (n = 4202)
PRAL (mEq/d)a −21.8 (−199.8 ~ −7.5) −2.9‡ (−11.3 ~ 8.2) 11.2‡ (−10.4 ~ 181.4) <0.001
DAL (mEq/d) 11.1 ± 20.8 35.9 ± 6.5‡ 53.4 ± 14.6‡ <0.001
Magnesium (mg/d) 388.0 ± 186.4 278.1 ± 139.4‡ 307.8 ± 177.2‡ <0.001
Age (year) 56.2 ± 10.3 57.1 ± 11.0‡ 56.8 ± 11.2‡ 0.001
Male (%) 41.4 41.3 41.8 0.881
Waist circumference (cm) 82.7 ± 9.0 82.5 ± 9.2 82.9 ± 9.3 0.255
BMI (kg/m2) 24.1 ± 3.0 23.9 ± 3.1‡ 24.0 ± 3.1 0.041
Systolic blood pressure (mmHg) 120.4 ± 17.2 122.1 ± 18.0‡ 122.2 ± 17.6‡ <0.001
Diastolic blood pressure (mmHg) 76.3 ± 10.1 76.8 ± 10.6 77.2 ± 10.5‡ 0.001
Fasting plasma glucose (mg/dL) 101.4 ± 27.5 100.5 ± 23.3 100.6 ± 24.9 0.213
Total cholesterol (mg/dL)b 193.2 ± 36.1 194.1 ± 36.7 194.3 ± 36.5 0.436
HDL cholesterol (mg/dL)b 51.1 ± 12.3 51.1 ± 12.6 51.2 ± 12.5 0.842
Triglycerides (mg/dL)b 138.8 ± 102.7 145.5 ± 119.8‡ 144.7 ± 113.5‡ 0.004
LDL cholesterol (mg/dL)b 119.0 ± 32.4 119.2 ± 32.6 119.0 ± 32.3 0.043
Creatinine (mg/dL) 0.8 ± 0.2 0.8 ± 0.2 0.8 ± 0.3 0.903
eGFR (mL/min/1.73 m2) 88.3 ± 14.9 87.9 ± 15.0 88.5 ± 15.5 0.193
Insulin (ųU/mL)b 9.8 ± 5.2 9.8 ± 5.9 10.0 ± 6.5 0.807
HOMA‑IRb 2.5 ± 1.9 2.5 ± 1.8 2.5 ± 2.5 0.962
Urine pH 5.8 ± 0.9 5.7 ± 0.9 5.7 ± 0.8‡ 0.013
Heavy drink (%) 12.3 14.1 17.0‡ <0.001
Current smoking (%) 15.4 17.8‡ 20.0‡ <0.001
Exercise (%) 28.3 24.6‡ 24.6‡ <0.001
Hypertension (%) 34.4 37.9‡ 38.5‡ <0.001
IFG/Diabetes (%) 23.3/13.4 24.2/13.4 25.0/12.7 0.427
Metabolic syndrome (%) 37.1 38.8 40.2‡ 0.014
Chronic kidney disease (%) 3.8 4.3 4.5 0.263
Region (Metro/City/Rural,  %) 43.3/30.2/26.5 42.3/31.5/26.3 41.7/30.2/28.1 0.237
Family history of cardio‑ or cerebro‑vascular disease (%) 6.6 6.3 6.7 0.811
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in the general population. Diet-induced acid load was 
closely linked with CVD risk especially among middle-
aged individuals. In addition, higher PRAL scores were 
associated with CVD risk independent of obesity, exer-
cise, and insulin resistance, but not sarcopenia. This 
association remained significant after adjusting for other 
essential confounding factors.
To date, the health effects of acid–base imbalance were 
mainly investigated in bone mass [33], and kidney stones 
[34]. Recently, studies on systemic metabolism were con-
ducted that extended the effects of diet-induced acid load 
on one’s body. For example, a prospective study showed 
that higher PRAL scores correlated with the incidence of 
type 2 diabetes (hazard ratio = 1.56, 95 % CI 1.29‒1.90) 
[7]. Similarly, a Japanese study reported men with high-
est PRAL quartile had 61  % increased type 2 diabe-
tes prevalence in over 5  years follow-up period [35]. In 
addition, individuals with higher diet-induced acid load 
were reported to exhibit 27 % increases on hypertension 
development regardless of age [8], and this positively cor-
related with the prevalence of nonalcoholic fatty liver 
disease [36]. In this study, we also demonstrated higher 
incidences of increased blood pressure, prevalence of 
hypertension and metabolic syndrome in conjunction 
with higher PRAL and DAL scores. In addition, individu-
als with higher diet-induced acid load tended to have 
Table 2 Baseline characteristics of study population by categories of DAL
‡ P < 0.05 by post hoc analyses when compared with lowest tertiles
* Chi square tests for qualitative variables and ANOVA tests for quantitative variables
PRAL potential renal acid load; DAL dietary acid load; BMI body mass index; HDL cholesterol, high density lipoprotein cholesterol; LDL cholesterol, low density 
lipoprotein cholesterol; eGFR estimated glomerular filtration rate; HOMA-IR homeostasis model assessment of insulin resistance; IFG impaired fasting glucose
a Values are medians per tertile
b Log-transformed
Tertiles of dietary DAL (mEq/day) P value*
T1 (n = 3900) T2 (n = 3839) T3 (n = 3826)
DAL (mEq/d)a 16.9 (−165.5 ~ 33.9) 36.1‡ (25.9 ~ 48.5) 51.9‡ (39.3 ~ 221.1) <0.001
PRAL (mEq/d) −27.5 ± 20.5 −2.2 ± 5.3‡ 15.4 ± 13.4‡ <0.001
Magnesium (mg/d) 381.4 ± 187.5 284.0 ± 146.0‡ 310.4 ± 177.0‡ <0.001
Age (year) 56.8 ± 10.5 57.4 ± 11.1‡ 55.9 ± 10.9‡ <0.001
Male (%) 40.8 40.5 43.0 0.062
Waist circumference (cm) 81.7 ± 8.8 82.1 ± 9.1 84.4 ± 9.4‡ <0.001
BMI (kg/m2) 23.7 ± 2.9 23.7 ± 3.1 24.5 ± 3.2‡ <0.001
Systolic blood pressure (mmHg) 120.5 ± 17.3 122.2 ± 18.3‡ 121.9 ± 17.2‡ <0.001
Diastolic blood pressure (mmHg) 76.1 ± 10.1 76.6 ± 10.5 77.6 ± 10.5‡ <0.001
Fasting plasma glucose (mg/dL) 101.3 ± 27.7 100.4 ± 24.5 100.9 ± 24.5 0.268
Total cholesterol (mg/dL)b 193.0 ± 36.2 194.2 ± 36.8 194.5 ± 36.2 0.146
HDL cholesterol (mg/dL)b 51.5 ± 12.4 51.3 ± 12.6 50.7 ± 12.3‡ 0.031
Triglycerides (mg/dL)b 137.4 ± 110.9 142.8 ± 106.1‡ 148.7 ± 118.9‡ <0.001
LDL cholesterol (mg/dL)b 118.7 ± 32.5 119.4 ± 32.8 119.0 ± 32.0 0.613
Creatinine (mg/dL) 0.8 ± 0.2 0.8 ± 0.2 0.9 ± 0.3 0.085
GFR, EPI (mL/min/1.73 m2) 88.3 ± 14.9 87.7 ± 15.1 88.8 ± 15.5 0.011
Insulin (μU/mL)b 9.5 ± 4.8 9.8 ± 5.8 10.3 ± 6.7‡ <0.001
HOMA‑IRb 2.4 ± 1.8 2.5 ± 1.8 2.6 ± 2.6‡ <0.001
Urine pH 5.8 ± 0.9 5.7 ± 0.9 5.7 ± 0.8‡ 0.001
Heavy drink (%) 12.1 13.9 17.8‡ <0.001
Current smoking (%) 15.7 17.4 20.3‡ <0.001
Exercise (%) 27.9 24.4‡ 25.3 <0.001
Hypertension (%) 34.4 37.6‡ 38.7‡ <0.001
IFG/diabetes (%) 22.8/13.3 24.0/13.2 25.9/13.0 0.918
Metabolic syndrome (%) 35.1 38.1‡ 43.1‡ <0.001
Chronic kidney disease (%) 3.8 4.5 4.2 0.376
Region (Metro/City/rural,  %) 42.5/30.2/27.3 43.2/30.6/26.3 41.6/30.9/27.5 0.613
Family history of cardio‑ or cerebro‑vascular disease (%) 6.5 6.6 6.6 0.984
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unhealthy lifestyle patterns during relatively younger 
ages, including less physical activity, stricter adherence 
to Western diet patterns, and higher BMI, in accordance 
with previous studies [7, 8, 36]. This was consistent with 
our findings that in the highest PRAL score group, indi-
viduals were more likely to exhibit sedentary patterns, 
increased waist circumferences, and high prevalence of 
smoking and drinking alcohol.
Diet‑induced acid load, cardiovascular diseases 
and possible mechanisms
The mechanism linking diet-induced acid load and met-
abolic disease incidence is mainly reported as insulin 
resistance [7, 9]. Toward that end, insulin binding affin-
ity to its receptor was markedly decreased in individu-
als with metabolic acidosis [37]. Thus, even in healthy 
individuals, a very low degree of metabolic acidosis 
could lead to insulin resistance, resulting hyperglycemia 
[38]. Moreover, a previous study reported that attenuat-
ing metabolic acidosis could increase insulin sensitivity 
[39]. In accordance with this evidence, our study results 
demonstrated that the highest DAL tertile was associ-
ated with increased values of HOMA-IR. Regarding the 
effect of diet-induced acid load on blood pressure, sev-
eral mechanisms have been suggested. A diet depleted 
of potassium could affect vasodilatation and be toxic to 
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the blood vessels [40]. Potassium restriction results in 
intracellular potassium deficits and causes compensa-
tory sodium gains in cells to maintain tonicity and vol-
ume [40]. In a human study, even a 10 day period of low 
potassium intake increased systolic blood pressure by 
5 mmHg (P < 0.02) and modified salt sensitivity, resulting 
in exacerbation of hypertension [41]. Conversely, hyper-
tensive rats fed a potassium-rich diet showed decreases 
in blood pressure and stroke development [42, 43]. Like-
wise, our study demonstrated that PRAL and DAL scores 
were positively associated with both systolic and diastolic 
blood pressure values, as well as hypertension prevalence 
(OR 1.19, 95 % CI 1.09‒1.31). In addition, systemic meta-
bolic acidosis, caused by the Western diet, is associated 
with excessive cortisol levels and leads to ammoniagen-
esis, which may lead to loss of renal function [12, 44]. 
Diet-induced insulin resistance could autonomously pro-
mote cardiovascular disease in various pathways; impair 
coronary microcirculatory function [45], stimulate con-
duction dysfunction and increase arrhythmogenesis [46].
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Diet‑induced acid load in unhealthy states
Previously, the correlation between diet-acid load and 
metabolic disease was stronger in non-obese individuals, 
suggesting that it is independent of adiposity [7, 9]. We 
evaluated the PRAL score and ACC/AHA ASCVD risk 
according to BMI as well as insulin resistance. Although 
this association remained significant in both lean/over-
weight and insulin sensitive/resistant groups, more 
substantial correlations were observed in lean individu-
als (OR  1.37 vs 1.19) and in the insulin sensitive group 
(OR  1.34 vs 1.21). Moreover, there was no significant 
difference in risk of ACC/AHA ASCVD between lean 
subjects with higher PRAL scores and those in the 
overweight group in the lowest PRAL tertile, suggest-
ing that CVD risk of lean individuals would increase if 
diet-induced acid loads were elevated. An epidemiologic 
study that reported that dietary patterns could increase 
the risk of obesity, even in lean individuals, suggests that 
diet affects metabolism in non-obese populations [47]. In 
addition, if sedentary individuals lowered their intake of 
dietary acid, they might exhibit comparable CVD risks 
with people who regularly exercised. While obesity and 
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exercise are major contributing factors to CVD risk, diet-
induced acid load might modify these effects. Regard-
less, the association between diet-induced acid load and 
CVD risk with respect to muscle mass seems compel-
ling. There has been some evidence that sarcopenia could 
influence CVD, such as increased arterial stiffness and 
inflammatory markers in people with sarcopenia [48, 49]. 
Our results also demonstrated increased CVD risk in the 
sarcopenic group compared to the non-sarcopenic group; 
however, the association between PRAL score and ACC/
AHA ASCVD risk did not remain significant among sar-
copenic individuals. Furthermore, subjects with higher 
PRAL scores but preserved muscle mass had lower CVD 
risk than those in the sarcopenic group with lower PRAL 
scores. This might suggest that skeletal muscle mass is 
more closely associated with lower CVD risks compared 
to healthy diet patterns.
This study has some limitations. First, our cross-sec-
tional study design could not conclude causality between 
diet-induced acid load and CVD risk. Second, PRAL and 
DAL scores were derived from self-reports using a 24 h 
recall method, which only confirmed the short term die-
tary intakes of the study participants; the daily variation 
in food consumption could not be considered. Third, we 
could not assess the quality of protein that was used to 
calculate PRAL and DAL scores. In addition, KHNASE 
did not collect each individual’s medication information, 
and not evaluate physical performance status, and mus-
cle strength. Sarcopenic status was classified by muscle 
mass alone, not considering muscle strength or physical 
performance. The potential medication effect on CVD 
risk was not considered in our results.
Despite these limitations, the current study had several 
strengths. First, it was a large population study based on 
national data, guaranteeing the statistical reliability of 
results. As KNHANES represents the non-institution-
alized general population, selection bias was minimized. 
Second, this investigation provided strong evidence of 
a close relationship between diet-induced acid load and 
CVD risk by adjusting for other confounding factors 
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and conducting stratification analyses. To the best of 
our knowledge, this is the first large-scale study to esti-
mate the CVD risk associated with diet-induced acid 
load. We assessed diet-induced acid load using vari-
able methods: PRAL and DAL scores. The correlation 
between PRAL and DAL scores was high (Pearson cor-
relation coefficient = 0.99, P < 0.001) in our study, which 
was consistent with previous studies [10]. Third, indi-
vidual CVD risks were estimated using various equa-
tions, and comparable results were derived regardless 
of these different models. Fourth, although the current 
study was cross-sectional, we limited the study popula-
tion by excluding those with prior CVD history to pre-
vent reverse causality.
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In the light of dietary pattern and CVD risk, our study 
results demonstrate that individuals with higher diet-
induced acid load are more vulnerable to CVD risks. 
Despite advances in CVD diagnostic and treatment 
modalities, prevention is the most high-leverage action, 
and therefore, modifiable risk factors are important. Pro-
spective, well-designed, longitudinal studies with sufficient 
laboratory and cardiovascular-imaging resources are war-
ranted to elucidate the complex relationship between diet-
induced acid load and CVD risk. If the causality between 
diet-induced acid load and CVD risk, as well as the cut-
off value of diet-induced acid load are clearly investigated, 
then meaningful, comprehensive, and practical dietary 
recommendations would be provided to the public.
Conclusions
This nationwide survey of a representative sample of the 
Korean population demonstrated that diet-induced acid 
load was associated with increased risks of CVD, inde-
pendent of other cardiovascular factors.
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Table 3 Odds ratio and 95 % confidential interval of high 
ASCVD risk (>10  % 2013 ACC/AHA score) according 
to PRAL tertiles in adults
Model 1: adjusted for age (per 5 years), and sex
Model 2: adjusted for age (per 5 years), sex, exercise, and family history of cardio- 
and cerebro-vascular disease
Model 3: adjusted for age (per 5 years), sex, exercise, family history of cardio- and 
cerebro-vascular disease, diabetes, hypertension, LDL cholesterol, eGFR, and 
urine pH
ASCVD 10 year atherosclerotic vascular disease; PRAL potential renal acid 
load; eGFR estimated glomerular filtration rate; LDL cholesterol; low density 
lipoprotein cholesterol
Lowest tertile Second tertile Highest tertile
Crude 1 (referent) 1.27 (1.15–1.40) 1.23 (1.22–1.35)
Model 1 1 (referent) 1.29 (1.11–1.51) 1.18 (1.02–1.36)
Model 2 1 (referent) 1.28 (1.10–1.50) 1.17 (1.01–1.35)
Model 3 1 (referent) 1.31 (1.09–1.58) 1.20 (1.01–1.43)
Table 4 Odds ratio and 95 % confidential interval of high 
ASCVD risk (>10 % 2013 ACC/AHA score) according to DAL 
tertiles in adults
Model 1: adjusted for age (per 5 years), and sex
Model 2: adjusted for age (per 5 years), sex, exercise, and family history of cardio- 
and cerebro-vascular disease
Model 3: adjusted for age (per 5 years), sex, exercise, family history of cardio- and 
cerebro-vascular disease, diabetes, hypertension, LDL cholesterol, eGFR, and 
urine pH
ASCVD 10 year atherosclerotic vascular disease; DAL dietary acid load; eGFR 
estimated glomerular filtration rate; LDL cholesterol; low density lipoprotein 
cholesterol
Lowest tertile Second tertile Highest tertile
Crude 1 (referent) 1.21 (1.10–1.33) 1.00 (0.90–1.09)
Model 1 1 (referent) 1.24 (1.07–1.44) 1.16 (1.00–1.35)
Model 2 1 (referent) 1.23 (1.06–1.43) 1.15 (0.99–1.34)
Model 3 1 (referent) 1.25 (1.04–1.46) 1.07 (0.89–1.28)
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